Taken together, these observations position CSPG4, xCT, and TLR2 as a novel, interconnected set of promising biomarkers and putative therapeutic targets in OSA, warranting further mechanistic and translational investigation. The gene discussed is SLC7A11; the disease is obstructive sleep apnea syndrome.